Evidence That HIV-1 CRF01_AE Is Associated with Low CD4+T Cell Count and CXCR4 Co-Receptor Usage in Recently Infected Young Men Who Have Sex with Men (MSM) in Shanghai, China
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evidence That HIV-1 CRF01_AE Is Associated with Low CD4+T Cell Count and CXCR4 Co-Receptor Usage in Recently Infected Young Men Who Have Sex with Men (MSM) in Shanghai, China
Authors
Keywords
HIV-1, Viral tropism, Men who have sex with men, Sequence databases, Algorithms, Coreceptors, Phylogenetic analysis, China
Journal
PLoS One
Volume 9, Issue 2, Pages e89462
Publisher
Public Library of Science (PLoS)
Online
2014-02-22
DOI
10.1371/journal.pone.0089462
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s
- (2013) Yi Feng et al. AIDS
- Determination of the High Prevalence of Dual/Mixed- or X4-Tropism Among HIV Type 1 CRF01_AE in Hong Kong by Genotyping and Phenotyping Methods
- (2013) Sabrina Wai-Chi To et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- High prevalence of CXCR4 usage among treatment-naive CRF01_AE and CRF51_01B-infected HIV-1 subjects in Singapore
- (2013) Kah Ying Ng et al. BMC INFECTIOUS DISEASES
- HIV and Syphilis Prevalence Among Men Who Have Sex With Men: A Cross-Sectional Survey of 61 Cities in China
- (2013) Zunyou Wu et al. CLINICAL INFECTIOUS DISEASES
- Identification of 3 Distinct HIV-1 Founding Strains Responsible for Expanding Epidemic Among Men Who Have Sex With Men in 9 Chinese Cities
- (2013) Xiaoxu Han et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- New Emerging Recombinant HIV-1 Strains and Close Transmission Linkage of HIV-1 Strains in the Chinese MSM Population Indicate a New Epidemic Risk
- (2013) Jianjun Wu et al. PLoS One
- HIV-1 Tropism Determination Using a Phenotypic Env Recombinant Viral Assay Highlights Overestimation of CXCR4-Usage by Genotypic Prediction Algorithms for CRRF01_AE and CRF02_AG
- (2013) Martin Mulinge et al. PLoS One
- Recent HIV-1 Infection Contributes to the Viral Diffusion over the French Territory with a Recent Increasing Frequency
- (2012) Pierre Frange et al. PLoS One
- A Comprehensive Mapping of HIV-1 Genotypes in Various Risk Groups and Regions across China Based on a Nationwide Molecular Epidemiologic Survey
- (2012) Xiang He et al. PLoS One
- Predicted HIV-1 coreceptor usage among Kenya patients shows a high tendency for subtype d to be cxcr4 tropic
- (2012) Veronica Wambui et al. AIDS Research and Therapy
- HIV-1 Dual Infection Is Associated With Faster CD4+ T-Cell Decline in a Cohort of Men With Primary HIV Infection
- (2011) M. Cornelissen et al. CLINICAL INFECTIOUS DISEASES
- Ambiguous Nucleotide Calls From Population-based Sequencing of HIV-1 are a Marker for Viral Diversity and the Age of Infection
- (2011) Roger D. Kouyos et al. CLINICAL INFECTIOUS DISEASES
- Presence of CXCR4-Using HIV-1 in Patients With Recently Diagnosed Infection: Correlates and Evidence for Transmission
- (2011) Kristen Chalmet et al. JOURNAL OF INFECTIOUS DISEASES
- Selective transmission of R5 HIV-1 variants: where is the gatekeeper?
- (2011) Jean-Charles Grivel et al. Journal of Translational Medicine
- European guidelines on the clinical management of HIV-1 tropism testing
- (2011) LPR Vandekerckhove et al. LANCET INFECTIOUS DISEASES
- Increased Rate of CD4+ T-Cell Decline and Faster Time to Antiretroviral Therapy in HIV-1 Subtype CRF01_AE Infected Seroconverters in Singapore
- (2011) Oon Tek Ng et al. PLoS One
- HIV Incidence among Men Who Have Sex with Men in China: A Meta-Analysis of Published Studies
- (2011) Hong-Min Li et al. PLoS One
- Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy
- (2010) Philippa J Easterbrook et al. Journal of the International AIDS Society
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started